Advertisement

Person › Details
Peter Chambré (Cambridge Antibody Technology Group plc (CAT))
Chambré, Peter (Cambridge Antibody 200204– CEO before Celera Genomics COO before Bespak CEO)
![]() |
Product | BIOTECH |
Record changed: 2024-07-31 |
Advertisement

More documents for Peter Chambré
- [1] Immatics N.V.. (7/31/24). "Press Release: Immatics Appoints Alise Reicin to Board of Directors". Houston, TX & Tübingen....
- [2] Immatics N.V.. (9/15/20). "Press Release: Immatics Appoints Biotech Executive Eliot Forster to Board of Directors". Tübingen & Houston, TX....
- [3] Immatics Biotechnologies GmbH. (7/8/19). "Press Release: Immatics Appoints Harpreet Singh as Chief Executive Officer". Tübingen & Houston, TX....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement

» top